These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
72 related items for PubMed ID: 20818604
21. The reproducibility of 31-phosphorus MRS measures of muscle energetics at 3 Tesla in trained men. Edwards LM, Tyler DJ, Kemp GJ, Dwyer RM, Johnson A, Holloway CJ, Nevill AM, Clarke K. PLoS One; 2012; 7(6):e37237. PubMed ID: 22701564 [Abstract] [Full Text] [Related]
22. Effect of vitamin D supplementation on muscle energy phospho-metabolites: a ³¹P magnetic resonance spectroscopy-based pilot study. Rana P, Marwaha RK, Kumar P, Narang A, Devi MM, Tripathi RP, Khushu S. Endocr Res; 2014; 39(4):152-6. PubMed ID: 24679100 [Abstract] [Full Text] [Related]
24. A prospective study to evaluate the impact of 31P-MRS to determinate mitochondrial dysfunction in skeletal muscle of ALS patients. Grehl T, Fischer S, Müller K, Malin JP, Zange J. Amyotroph Lateral Scler; 2007 Feb; 8(1):4-8. PubMed ID: 17364428 [Abstract] [Full Text] [Related]
25. Creatine has no beneficial effect on skeletal muscle energy metabolism in patients with single mitochondrial DNA deletions: a placebo-controlled, double-blind 31P-MRS crossover study. Kornblum C, Schröder R, Müller K, Vorgerd M, Eggers J, Bogdanow M, Papassotiropoulos A, Fabian K, Klockgether T, Zange J. Eur J Neurol; 2005 Apr; 12(4):300-9. PubMed ID: 15804248 [Abstract] [Full Text] [Related]
26. Serum concentrations of NSE and S100B in spinocerebellar ataxia type 3/Machado-Joseph disease. Zhou J, Lei L, Shi Y, Wang J, Jiang H, Shen L, Tang B. Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):504-10. PubMed ID: 21743141 [Abstract] [Full Text] [Related]
27. Phosphocreatine resynthesis during recovery in different muscles of the exercising leg by 31P-MRS. Yoshida T, Abe D, Fukuoka Y. Scand J Med Sci Sports; 2013 Oct; 23(5):e313-9. PubMed ID: 23662804 [Abstract] [Full Text] [Related]
28. [Iodine-123-labeled meta-iodobenzylguanidine myocardial scintigraphy evaluation of Machado-Joseph disease]. Kazuta T, Hayashi M, Yoshita M, Hirai S. Rinsho Shinkeigaku; 1998 Feb; 38(2):97-101. PubMed ID: 9619069 [Abstract] [Full Text] [Related]
29. Spin labeling artery method perfusion MRI study of SPG4 and SCA3/MJD. Xing W, Wang XY, Liao XX, Liao WH, Shen L. Magn Reson Imaging; 2014 Dec; 32(10):1330-4. PubMed ID: 25172988 [Abstract] [Full Text] [Related]
30. Failure of brain and skeletal muscle energy metabolism in multiple system atrophy shown by in vivo phosphorous MR spectroscopy. Martinelli P, Giuliani S, Lodi R, Iotti S, Zaniol P, Barbiroli B. Adv Neurol; 1996 Dec; 69():271-7. PubMed ID: 8615139 [No Abstract] [Full Text] [Related]
31. Decreased antioxidant enzyme activity and increased mitochondrial DNA damage in cellular models of Machado-Joseph disease. Yu YC, Kuo CL, Cheng WL, Liu CS, Hsieh M. J Neurosci Res; 2009 Jun; 87(8):1884-91. PubMed ID: 19185026 [Abstract] [Full Text] [Related]
32. High-energy phosphate metabolism during incremental calf exercise in patients with unilaterally symptomatic peripheral arterial disease measured by phosphor 31 magnetic resonance spectroscopy. Greiner A, Esterhammer R, Messner H, Biebl M, Mühlthaler H, Fraedrich G, Jaschke WR, Schocke MF. J Vasc Surg; 2006 May; 43(5):978-86. PubMed ID: 16678693 [Abstract] [Full Text] [Related]
33. Striatal and nigral pathology in a lentiviral rat model of Machado-Joseph disease. Alves S, Régulier E, Nascimento-Ferreira I, Hassig R, Dufour N, Koeppen A, Carvalho AL, Simões S, de Lima MC, Brouillet E, Gould VC, Déglon N, de Almeida LP. Hum Mol Genet; 2008 Jul 15; 17(14):2071-83. PubMed ID: 18385100 [Abstract] [Full Text] [Related]
34. Pattern of peripheral nerve involvement in Machado-Joseph disease: neuronopathy or distal axonopathy? A clinical and neurophysiological evaluation. Escorcio Bezerra ML, Pedroso JL, Pinheiro DS, Braga-Neto P, Povoas Barsottini OG, Braga NI, Manzano GM. Eur Neurol; 2013 Jul 15; 69(3):129-33. PubMed ID: 23234876 [Abstract] [Full Text] [Related]
35. The time course of haemodynamic, autonomic and skeletal muscle metabolic abnormalities following first extensive myocardial infarction in man. Adamopoulos S, Kemp GJ, Thompson CH, Arnolda L, Brunotte F, Stratton JR, Radda GK, Rajagopalan B, Kremastinos DT, Coats AJ. J Mol Cell Cardiol; 1999 Oct 15; 31(10):1913-26. PubMed ID: 10525428 [Abstract] [Full Text] [Related]
36. Interrelation of 31P-MRS metabolism measurements in resting and exercised quadriceps muscle of overweight-to-obese sedentary individuals. Valkovič L, Ukropcová B, Chmelík M, Baláž M, Bogner W, Schmid AI, Frollo I, Zemková E, Klimeš I, Ukropec J, Trattnig S, Krššák M. NMR Biomed; 2013 Dec 15; 26(12):1714-22. PubMed ID: 23949699 [Abstract] [Full Text] [Related]
37. Sleep symptoms and their clinical correlates in Machado-Joseph disease. D'Abreu A, França M, Conz L, Friedman JH, Nucci AM, Cendes F, Lopes-Cendes I. Acta Neurol Scand; 2009 Apr 15; 119(4):277-80. PubMed ID: 18771522 [Abstract] [Full Text] [Related]
38. Flattened facial colliculus on magnetic resonance imaging in Machado-Joseph disease. Ogawa Y, Ito S, Makino T, Kanai K, Arai K, Kuwabara S. Mov Disord; 2012 Jul 15; 27(8):1041-6. PubMed ID: 22693147 [Abstract] [Full Text] [Related]
39. Effect of anaemia correction on skeletal muscle metabolism in patients with end-stage renal disease: 31P magnetic resonance spectroscopy assessment. Thompson RT, Muirhead N, Marsh GD, Gravelle D, Potwarka JJ, Driedger AA. Nephron; 1996 Jul 15; 73(3):436-41. PubMed ID: 8832604 [Abstract] [Full Text] [Related]